Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

标题
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy
作者
关键词
Bladder cancer, Immunotherapy, CXCL13, Tertiary lymphoid structures, Response to immunotherapy
出版物
EUROPEAN JOURNAL OF CANCER
Volume 148, Issue -, Pages 181-189
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.ejca.2021.01.036

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now